Jeff Yass’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Jeff Yass’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,100	Closed	-$450K	–	14535
2022 Q1	$450K	Buy	24,100 +14,700	+156%	+$265K	﹤0.01%	9247
2021 Q4	$201K	Buy	+9,400	New	+$185K	﹤0.01%	11445
2021 Q3	–	Sell	-94,700	Closed	-$2.03M	–	13952
2021 Q2	$2.03M	Buy	94,700 +15,600	+20%	+$317K	﹤0.01%	5888
2021 Q1	$1.53M	Buy	+79,100	New	+$1.39M	﹤0.01%	6596

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jeff Yass's OCDX Position: Q2 2022 in Review

Jeff Yass sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 46,519 shares — an estimated $868K sold.

Jeff Yass first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $1.52M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Jeff Yass reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Jeff Yass sold 46,519 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $868K.
Jeff Yass first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
Jeff Yass's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.52M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.